This is an instance where these big pharmaceutical companies would make most of their sales in the United States, then they race overseas to, in effect, pretend that they were really residents there so they could pay very low taxes.
Editor's note · Context
Wyden highlights tax avoidance practices by pharmaceutical companies.
Share & report
More from Ron Wyden
Well said, Senator Whitehouse. And I want to get my colleagues into this. Next in order of appearance is Senator Van Hollen. Once again, I want everybody to understand that the four of us are going to continue to go after this colossal tax…
Mr. President, 4 years ago, I kicked off an investigation of Big Pharma's tax practices, the dodges and tricks these hugely profitable, multinational companies use to winnow down their tax bills. This was not very long after Trump's first…
Mr. President, I am going to take a few minutes to walk through these findings and discuss why they are so important. I am very pleased to be joined by several of my colleagues who are also outraged about this tax-dodging. Here is the…
Senate Republicans would pay for those new corporate tax breaks by making even deeper cuts to Medicaid, slashing funding for rural hospitals and other essential health care providers and throwing cash-strapped states off a funding cliff.





